ÀºÇòÅâÂÊ

Home Food & Beverages Cannabis Market Size, Growth & Report Analysis by 2033

Cannabis Market Size, Share & Trends Analysis Report By Product Type (Capsules, Concentrates, Edibles, Other Product Types), By Application (Medical, Recreational), By Compound Type (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Balanced THC and CBD) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRFB3401DR
Author : ÀºÇòÅâÂÊ

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Cannabis Market Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Capsules
        1. By Value
      3. Concentrates
        1. By Value
      4. Edibles
        1. By Value
      5. Other Product Types
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Medical
        1. By Value
      3. Recreational
        1. By Value
    4. By Compound Type
      1. Introduction
        1. Compound Type By Value
      2. Tetrahydrocannabinol (THC)
        1. By Value
      3. Cannabidiol (CBD)
        1. By Value
      4. Balanced THC and CBD
        1. By Value
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Capsules
        1. By Value
      3. Concentrates
        1. By Value
      4. Edibles
        1. By Value
      5. Other Product Types
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Medical
        1. By Value
      3. Recreational
        1. By Value
    4. By Compound Type
      1. Introduction
        1. Compound Type By Value
      2. Tetrahydrocannabinol (THC)
        1. By Value
      3. Cannabidiol (CBD)
        1. By Value
      4. Balanced THC and CBD
        1. By Value
    5. U.S.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Capsules
          1. By Value
        3. Concentrates
          1. By Value
        4. Edibles
          1. By Value
        5. Other Product Types
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Medical
          1. By Value
        3. Recreational
          1. By Value
      3. By Compound Type
        1. Introduction
          1. Compound Type By Value
        2. Tetrahydrocannabinol (THC)
          1. By Value
        3. Cannabidiol (CBD)
          1. By Value
        4. Balanced THC and CBD
          1. By Value
    6. Canada
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Capsules
        1. By Value
      3. Concentrates
        1. By Value
      4. Edibles
        1. By Value
      5. Other Product Types
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Medical
        1. By Value
      3. Recreational
        1. By Value
    4. By Compound Type
      1. Introduction
        1. Compound Type By Value
      2. Tetrahydrocannabinol (THC)
        1. By Value
      3. Cannabidiol (CBD)
        1. By Value
      4. Balanced THC and CBD
        1. By Value
    5. U.K.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Capsules
          1. By Value
        3. Concentrates
          1. By Value
        4. Edibles
          1. By Value
        5. Other Product Types
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Medical
          1. By Value
        3. Recreational
          1. By Value
      3. By Compound Type
        1. Introduction
          1. Compound Type By Value
        2. Tetrahydrocannabinol (THC)
          1. By Value
        3. Cannabidiol (CBD)
          1. By Value
        4. Balanced THC and CBD
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Capsules
        1. By Value
      3. Concentrates
        1. By Value
      4. Edibles
        1. By Value
      5. Other Product Types
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Medical
        1. By Value
      3. Recreational
        1. By Value
    4. By Compound Type
      1. Introduction
        1. Compound Type By Value
      2. Tetrahydrocannabinol (THC)
        1. By Value
      3. Cannabidiol (CBD)
        1. By Value
      4. Balanced THC and CBD
        1. By Value
    5. China
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Capsules
          1. By Value
        3. Concentrates
          1. By Value
        4. Edibles
          1. By Value
        5. Other Product Types
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Medical
          1. By Value
        3. Recreational
          1. By Value
      3. By Compound Type
        1. Introduction
          1. Compound Type By Value
        2. Tetrahydrocannabinol (THC)
          1. By Value
        3. Cannabidiol (CBD)
          1. By Value
        4. Balanced THC and CBD
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Capsules
        1. By Value
      3. Concentrates
        1. By Value
      4. Edibles
        1. By Value
      5. Other Product Types
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Medical
        1. By Value
      3. Recreational
        1. By Value
    4. By Compound Type
      1. Introduction
        1. Compound Type By Value
      2. Tetrahydrocannabinol (THC)
        1. By Value
      3. Cannabidiol (CBD)
        1. By Value
      4. Balanced THC and CBD
        1. By Value
    5. UAE
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Capsules
          1. By Value
        3. Concentrates
          1. By Value
        4. Edibles
          1. By Value
        5. Other Product Types
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Medical
          1. By Value
        3. Recreational
          1. By Value
      3. By Compound Type
        1. Introduction
          1. Compound Type By Value
        2. Tetrahydrocannabinol (THC)
          1. By Value
        3. Cannabidiol (CBD)
          1. By Value
        4. Balanced THC and CBD
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Capsules
        1. By Value
      3. Concentrates
        1. By Value
      4. Edibles
        1. By Value
      5. Other Product Types
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Medical
        1. By Value
      3. Recreational
        1. By Value
    4. By Compound Type
      1. Introduction
        1. Compound Type By Value
      2. Tetrahydrocannabinol (THC)
        1. By Value
      3. Cannabidiol (CBD)
        1. By Value
      4. Balanced THC and CBD
        1. By Value
    5. Brazil
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Capsules
          1. By Value
        3. Concentrates
          1. By Value
        4. Edibles
          1. By Value
        5. Other Product Types
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Medical
          1. By Value
        3. Recreational
          1. By Value
      3. By Compound Type
        1. Introduction
          1. Compound Type By Value
        2. Tetrahydrocannabinol (THC)
          1. By Value
        3. Cannabidiol (CBD)
          1. By Value
        4. Balanced THC and CBD
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Cannabis Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Tilray
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Canopy Growth Corp
    3. GW Pharmaceuticals PLC
    4. Aurora Cannabis Inc.
    5. Aphira Inc.
    6. MedReLeaf Corp
    7. CV sciences Inc.
    8. Delta 9 Cannabis
    9. Cannimed Therapeutics Inc.
    10. Vivo Cannabis
    11. Good Leaf
    12. Halo Labs
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Cannula Market Size The global cannula market size was valued at USD 186.67 million in 2024 and is projected to reach from USD 200.17 million in 2025 to USD 349.88 million by 2033 at a CAGR of 7.23% during the forecast period (2025-2033). Facto
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :